Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endocrine Therapy With or Without Cryoablation for Stage IV Prostate Cancer
NCT02615223Unknown
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Start
- Nov 2015
- Primary completion
- Dec 2017
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by Tianjin Medical University Cancer Institute and Hospital. Primary endpoints: Biochemical Progression-Free Survival at 12 months and Quality of Life at 12 months. Status: unknown.
Beyond the preview
Go deeper on NCT02615223.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02615223.